Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
Open accessThe DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
There are more than 2 billion overweight and obese individuals worldwide, surpassing for the first time, the number of people affected by undernutrition. Obesity and its comorbidities inflict a heavy burden on the global economies and have become a serious threat to individuals' wellbeing with no immediate cure available. The causes of obesity are manifold, involving several factors including physiological, metabolic, neural, psychosocial, economic, genetics and the environment, among others. Recent advances in genome sequencing and metagenomic profiling have added another dimension to this complexity by implicating the gut microbiota as an important player in energy regulation and the development of obesity. As such, accumulating evidence demonstrate the impact of the gut microbiota on body weight, adiposity, glucose, lipid metabolism, and metabolic syndrome. This also includes the role of microbiota as a modulatory signal either directly or through its bioactive metabolites on intestinal lumen by releasing chemosensing factors known to have a major role in controlling food intake and regulating body weight. The importance of gut signaling by microbiota signaling is further highlighted by the presence of taste and nutrient receptors on the intestinal epithelium activated by the microbial degradation products as well as their role in release of peptides hormones controlling appetite and energy homeostasis. This review present evidence on how gut microbiota interacts with intestinal chemosensing and modulates the release and activity of gut peptides, particularly GLP-1 and PYY.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“This is also consistent with results from the study demonstrating that transplantation of gut microbiota from twins discordant for obesity into GFmice resulted in increased body mass and adiposity of mice receiving the obese co-twins microbiota compared to the lean co-twin, whether the groups were maintained on a low-…”
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781 · cited 2×
“Both propionate and acetate have been shown to reduce lipolysis, intrahepatic triglycerides and free fatty acids as well as improving insulin response in pancreatic β cells (57, 63, 64).”
BackgroundEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 5×
“Degradation of PYY(1-36) into PYY(3-36) is an important step for control of food intake.”
BackgroundInfluentialGut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 1×
“Similarly, elderly anorexia is associated with higher plasma levels of PYY (194), and microbiota changes occur with aging (195).”
BackgroundThe Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · cited 2×
“Indeed, HF-feeding of humanized gnotobiotic mice results in a rapid shift in microbiome and its metabolic pathways preceding increased adiposity (168) suggesting that direct microbe host crosstalk influences intestinal signaling mechanism.”
BackgroundEnergy contributions of volatile fatty acids from the gastrointestinal tract in various species
Bergman, E. N. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.567 · Cited by 2,750
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 1×
“It has been documented that germ-free mice utilize significantly less energy from the food consumed and are therefore leaner than conventional mice, despite eating more, an effect likely due to diminished, or absence of, signaling regulating satiety (135).”
BackgroundInfluence of diet on the gut microbiome and implications for human health
Singh, R. K., Chang, H.-W., Yan, D., Lee, K. M., Ucmak, D., Wong, K., Abrouk, M., Farahnik, B., Nakamura, M., Zhu, T. H., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1175-y · Cited by 2,599
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 6×
“Degradation of PYY(1-36) into PYY(3-36) is an important step for control of food intake.”
BackgroundInfluentialBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409 · cited 1×
“Activation of SCFA ligands, FFAR3, and FFAR2 induces high levels of circulating PYY (117), however their mediation of SCFAsinduced colonic PYY secretion has been recently questioned (47).”
BackgroundTolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Regulation of short-chain fatty acid production
Macfarlane, S., & Macfarlane, G. T. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2002207 · Cited by 1,939
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880 · cited 1×
“Akkermansia is drastically diminished in obese mice and humans but markedly enriched after gastric bypass (33, 184, 185) and in metformin-induced weight loss patients (186).”
BackgroundZmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R. B.-Z., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.041 · Cited by 1,695
High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity
Hildebrandt, M. A., Hoffmann, C., Sherrill–Mix, S. A., Keilbaugh, S. A., Hamady, M., Chen, Y., Knight, R., Ahima, R. S., Bushman, F., & Wu, G. D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.042 · Cited by 1,576 · cited 1×
“Similarly, genetically obese-resistant mice exhibit decreased Bacteroidetes, and increased Firmicutes during HF feeding, emphasizing that diet and not host phenotype may be the main determinant of microbiota shifts (169).”
BackgroundSamuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564 · cited 1×
“This was demonstrated in gnotobiotic models (128) where germ-free mice were colonized with a fermentative community composed of Bacteroides thetaiotaomicron and Methanobrevibacter smithii.”
BackgroundShin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Chambers, E. S., Viardot, A., Psichas, A., Morrison, D. J., Murphy, K. G., Zac-Varghese, S. E. K., MacDougall, K., Preston, T., Tedford, C., Finlayson, G. S., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307913 · Cited by 1,424
Reigstad, C. S., Salmonson, C. E., III, J. F. R., Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., & Kashyap, P. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-259598 · Cited by 1,335
Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome
Perry, R. J., Peng, L., Barry, N. A., Cline, G. W., Zhang, D., Cardone, R. L., Petersen, K. F., Kibbey, R. G., Goodman, A. L., & Shulman, G. I. (2016) · Nature · doi:10.1038/nature18309 · Cited by 1,299
Homeostatic Immunity and the Microbiota
Belkaid, Y., & Harrison, O. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.008 · Cited by 1,261 · cited 6×
“Degradation of PYY(1-36) into PYY(3-36) is an important step for control of food intake.”
BackgroundInfluentialγ-Aminobutyric acid production by culturable bacteria from the human intestine
Barrett, E., Ross, R. P., O'Toole, P. W., Fitzgerald, G. F., & Stanton, C. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05344.x · Cited by 1,156
Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M., & Kim, C. H. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.056 · Cited by 1,127
den Besten, G., Bleeker, A., Gerding, A., van Eunen, K., Havinga, R., van Dijk, T. H., Oosterveer, M. H., Jonker, J. W., Groen, A. K., Reijngoud, D.-J., et al. (2015) · Diabetes · doi:10.2337/db14-1213 · Cited by 1,125
Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., Possemiers, S., Van Holle, A., François, P., de Vos, W. M., et al. (2011) · Diabetes · doi:10.2337/db11-0227 · Cited by 1,076
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974 · cited 1×
“For example consumption of oligofructose or enhancing microbiota fermentation with prebiotics increases GLP-1 production (159).”
BackgroundTowards standards for human fecal sample processing in metagenomic studies
Costea, P. I., Zeller, G., Sunagawa, S., Pelletier, E., Alberti, A., Levenez, F., Tramontano, M., Driessen, M., Hercog, R., Jung, F.-E., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3960 · Cited by 893
Cani, P. D., Osto, M., Geurts, L., & Everard, A. (2012) · Gut Microbes · doi:10.4161/gmic.19625 · Cited by 864
Microbiota and diabetes: an evolving relationship
Tilg, H., & Moschen, A. R. (2014) · Gut · doi:10.1136/gutjnl-2014-306928 · Cited by 853
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Physiology · doi:10.1113/jp273106 · Cited by 813
Schneeberger, M., Everard, A., Gómez-Valadés, A. G., Matamoros, S., Ramírez, S., Delzenne, N. M., Gomis, R., Claret, M., & Cani, P. D. (2015) · Scientific Reports · doi:10.1038/srep16643 · Cited by 798 · cited 1×
“muciniphila levels are inversely associated to obesity and diabetes (181, 182) and its administration reduced body weight andmetabolic inflammation by reducing plasma lipopolysaccharide (LPS)-binding protein (LBP) and leptin, as well as inactivated LPS/LBP downstream signaling (182, 183).”
BackgroundGlucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733
Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452516 · Cited by 709
The role of short chain fatty acids in appetite regulation and energy homeostasis
Byrne, C. S., Chambers, E. S., Morrison, D. J., & Frost, G. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.84 · Cited by 707 · cited 1×
“To this end, the discovery 15 years ago that the orphan G-protein-coupled receptors, GPR43 and GPR41 (subsequently renamed FFAR2 and FFRA3, respectively), and later joined by the GPR109A, as well as intracellular signaling molecules inhibiting Lysine/Histone Deacetylase (HDACs), were activated by SCFA, paved the way i…”
BackgroundThe contribution of the large intestine to energy supplies in man
N I, M. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.2.338 · Cited by 691 · cited 1×
“These fermentation byproducts also play a regulatory role in energy metabolism of the host providing ∼10% of the daily caloric input (49, 50).”
BackgroundEnteroendocrine Cells: Chemosensors in the Intestinal Epithelium
Gribble, F. M., & Reimann, F. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105439 · Cited by 683
Edfalk, S., Steneberg, P., & Edlund, H. (2008) · Diabetes · doi:10.2337/db08-0307 · Cited by 587 · cited 1×
“Therefore, they are able to detect a long list of compounds such as: SCFA via free fatty acid receptors FFAR3, FFAR2 (45), and fatty acid transporter FATP4 (98), long chain fatty acids (LCFA) via GPR120 (99), and FFAR1 (100), fatty acid derivates such as oleoylethanolamide via GPR119 (101), primary bile acids through…”
BackgroundSteinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
Pathak, P., Xie, C., Nichols, R. G., Ferrell, J. M., Boehme, S., Krausz, K. W., Patterson, A. D., Gonzalez, F. J., & Chiang, J. Y. L. (2018) · Hepatology · doi:10.1002/hep.29857 · Cited by 567 · cited 2×
“These studies demonstrate how host intestinal signaling constituents can shape gut microbiota to regulate metabolic homeostasis (78).”
BackgroundBacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells
Chimerel, C., Emery, E., Summers, D. K., Keyser, U., Gribble, F. M., & Reimann, F. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.032 · Cited by 548 · cited 2×
“Several bacteria from Escherichia, Bacteroides, and Clostridium genera, among others, have been involved in production of indole that acts on voltage-gated K channels, enhancing Ca2+ entry thus stimulating GLP-1 secretion (73).”
BackgroundSpecialized metabolites from the microbiome in health and disease
Sharon, G., Garg, N., Debelius, J., Knight, R., Dorrestein, P. C., & Mazmanian, S. K. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.016 · Cited by 544
Ileal brake: a sensible food target for appetite control. A review
Maljaars, P. W. J., Peters, H. P. F., Mela, D. J., & Masclee, A. A. M. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.07.018 · Cited by 451
The gut microbiota in human energy homeostasis and obesity
Rosenbaum, M., Knight, R., & Leibel, R. L. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.002 · Cited by 450 · cited 1×
“Furthermore, obesity has been associated with a distinct and differing gut microbial communities compared to lean phenotype and that transfer of “obese” microbiota replicates the obese phenotype of the donor, as well as associated differences in the chemosensory, metabolic, and neural dysregulations (167).”
BackgroundAbsence of intestinal microbiota does not protect mice from diet-induced obesity
Fleissner, C. K., Huebel, N., Abd El-Bary, M. M., Loh, G., Klaus, S., & Blaut, M. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510001303 · Cited by 436
Gut microbiome and depression: what we know and what we need to know
Winter, G., Hart, R. A., Charlesworth, R. P. G., & Sharpley, C. F. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0072 · Cited by 394
Genetic and environmental control of host-gut microbiota interactions
Org, E., Parks, B. W., Joo, J. W. J., Emert, B., Schwartzman, W., Kang, E. Y., Mehrabian, M., Pan, C., Knight, R., Gunsalus, R., et al. (2015) · Genome Research · doi:10.1101/gr.194118.115 · Cited by 381 · cited 1×
“For example, Akkermansia municiphilla is less abundant in obese and type-2 diabetic mice and daily administration of Akkermansia municiphilla for 1 month reversed high-fat diet-induced obesity and type 2 diabetes (33, 58).”
BackgroundGut microbiota, enteroendocrine functions and metabolism
Cani, P. D., Everard, A., & Duparc, T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.008 · Cited by 378 · cited 9×
“muciniphila were associated with increased enteroendocrine L-cell activity, and secretion of GLP-1 and GLP-2 (187).”
BackgroundInfluentialEndocannabinoids–at the crossroads between the gut microbiota and host metabolism
Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.211 · Cited by 367 · cited 6×
“Degradation of PYY(1-36) into PYY(3-36) is an important step for control of food intake.”
BackgroundInfluentialThe role of peptide YY in appetite regulation and obesity
Karra, E., Chandarana, K., & Batterham, R. L. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164269 · Cited by 336 · cited 1×
“In addition to its major role in regulating energy intake and appetitive behavior (91) PYY is implicated in other physiological functions including inflammation (92), cell differentiation (93), and proliferation (94).”
BackgroundA Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter
Finucane, M. M., Sharpton, T. J., Laurent, T. J., & Pollard, K. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084689 · Cited by 321
The gut microbiome and obesity
John, G. K., & Mullin, G. E. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0528-7 · Cited by 304 · cited 1×
“However, the Bacteroidetes/Firmicutes ratio and its usefulness in predicting human obesity has been disputed (170, 171).”
BackgroundMcVey Neufeld, K. A., Mao, Y. K., Bienenstock, J., Foster, J. A., & Kunze, W. A. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12049 · Cited by 299 · cited 1×
“Finally, gut microbiota influence gut motility and secretion by interacting directly with intrinsic primary afferent neurons (IPANS) (208, 209).”
BackgroundAkkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice
Zhao, S., Liu, W., Wang, J., Shi, J., Sun, Y., Wang, W., Ning, G., Liu, R., & Hong, J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0054 · Cited by 298 · cited 1×
“muciniphila levels are inversely associated to obesity and diabetes (181, 182) and its administration reduced body weight andmetabolic inflammation by reducing plasma lipopolysaccharide (LPS)-binding protein (LBP) and leptin, as well as inactivated LPS/LBP downstream signaling (182, 183).”
BackgroundYusta, B., Baggio, L. L., Koehler, J., Holland, D., Cao, X., Pinnell, L. J., Johnson-Henry, K. C., Yeung, W., Surette, M. G., Bang, K. W. A., et al. (2015) · Diabetes · doi:10.2337/db14-1577 · Cited by 282 · cited 1×
“For example, administration of Exendin-4, a GLP-1 receptor agonist significantly reduced inflammatory cytokines and macrophage infiltration (153, 154).”
BackgroundFreeland, K. R., & Wolever, T. M. S. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509991863 · Cited by 275
Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice
Bagarolli, R. A., Tobar, N., Oliveira, A. G., Araújo, T. G., Carvalho, B. M., Rocha, G. Z., Vecina, J. F., Calisto, K., Guadagnini, D., Prada, P. O., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.08.006 · Cited by 266 · cited 8×
“Furthermore, probiotic administration increases expression of proglucagon mRNA and reduced expression of pattern recognition receptors (PRRs) CD-14 and NOD1 that might explain their effect on GLP-1 secretion and improvements in circulating LPS (161, 164).”
BackgroundInfluentialSimon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., Zivehe, F., Hwang, J.-H., Stehle, P., Pacini, G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2690 · Cited by 253
Kahles, F., Meyer, C., Möllmann, J., Diebold, S., Findeisen, H. M., Lebherz, C., Trautwein, C., Koch, A., Tacke, F., Marx, N., et al. (2014) · Diabetes · doi:10.2337/db14-0100 · Cited by 212
Regulation of gut luminal serotonin by commensal microbiota in mice
Hata, T., Asano, Y., Yoshihara, K., Kimura-Todani, T., Miyata, N., Zhang, X.-T., Takakura, S., Aiba, Y., Koga, Y., & Sudo, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180745 · Cited by 211 · cited 6×
“Degradation of PYY(1-36) into PYY(3-36) is an important step for control of food intake.”
BackgroundInfluentialIncreased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota
Duca, F. A., Swartz, T. D., Sakar, Y., & Covasa, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039748 · Cited by 181 · cited 1×
“Not surprisingly, they have fewer intestinal (but not colonic) endocrine cells compared to conventionalized animals and reduced PYY secretion and gene expression (137).”
BackgroundShort-Chain Fatty Acid Receptor and Its Contribution to Glucagon-Like Peptide-1 Release
Kaji, I., Karaki, S.-I., & Kuwahara, A. (2014) · Digestion · doi:10.1159/000356211 · Cited by 177 · cited 6×
“Degradation of PYY(1-36) into PYY(3-36) is an important step for control of food intake.”
BackgroundInfluentialMcVey Neufeld, K. A., Perez‐Burgos, A., Mao, Y. K., Bienenstock, J., & Kunze, W. A. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12534 · Cited by 142 · cited 1×
“Finally, gut microbiota influence gut motility and secretion by interacting directly with intrinsic primary afferent neurons (IPANS) (208, 209).”
BackgroundInflammation meets metabolic disease: Gut feeling mediated by GLP-1
Zietek, T., & Rath, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00154 · Cited by 131
The role of gut hormone peptide YY in energy and glucose homeostasis: Twelve years on
Manning, S., & Batterham, R. L. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170404 · Cited by 124
Dai, Y., Dai, D., Wang, X., Ding, Z., & Mehta, J. L. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6539-4 · Cited by 116
Steven, S., Hausding, M., Kröller-Schön, S., Mader, M., Mikhed, Y., Stamm, P., Zinßius, E., Pfeffer, A., Welschof, P., Agdauletova, S., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0465-x · Cited by 114 · cited 1×
“Conversely, inflammatory markers, such as endotoxin, IL-1, and IL-6 provoked GLP-1 secretion in mice, while endotoxininduced hyperinsulinemia was abrogated by GLP-1 receptor antagonists (155, 156).”
BackgroundThe role of peptide YY in regulating glucose homeostasis
Boey, D., Sainsbury, A., & Herzog, H. (2007) · Peptides · doi:10.1016/j.peptides.2006.07.031 · Cited by 77
Pouteau, E., Meirim, I., Métairon, S., & Fay, L. (2001) · Journal of Mass Spectrometry · doi:10.1002/jms.181 · Cited by 77 · cited 1×
“SCFAs are predominantly present in the colon at high concentrations although, low, micromolar levels can also be found in the circulation (51, 52).”
BackgroundCluny, N. L., Eller, L. K., Keenan, C. M., Reimer, R. A., & Sharkey, K. A. (2015) · Obesity · doi:10.1002/oby.21017 · Cited by 72 · cited 1×
“Long term consumption of dietary fiber caused a marked shift in microbiota composition in obese mice, with a higher count of Bacteroidetes and an over representation of specific strains such as Bifidobacteria, Lactobacilli (30) and Roseburia and decreased Clostridium leptum (130).”
BackgroundHe, L., Wong, C. K., Cheung, K. K., Yau, H. C., Fu, A., Zhao, H., Leung, K. M., Kong, A. P., Wong, G. W., Chan, P. K., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12063 · Cited by 70
Evaluation of prebiotic effects of high-purity galactooligosaccharides in vitro and in vivo
Department of Public Health Sciences, G. S., Hong, K. B., Kim, J. H., Neo Cremar Co. Ltd., S. 4.-8., Kwon, H. K., Neo Cremar Co. Ltd., S. 4.-8., Han, S. H., Institute for Biomaterials, K. U., Park, Y., Institute for Biomaterials, K. U., et al. (2016) · Food Technology and Biotechnology · doi:10.17113/ftb.54.02.16.4292 · Cited by 45 · cited 1×
“These changes have been associated with higher plasma levels of GLP-1 and PYY (28) as well as with significant upregulation of GLP-1 and PYY mRNA expression (131).”
BackgroundEnteroendocrine Cells: Metabolic Relays between Microbes and Their Host
Plovier, H., & Cani, P. D. (2017) · Endocrine Development · doi:10.1159/000475736 · Cited by 36 · cited 6×
“Degradation of PYY(1-36) into PYY(3-36) is an important step for control of food intake.”
BackgroundInfluentialNilsson, A., Johansson-Boll, E., Sandberg, J., & Björck, I. (2016) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2016.06.006 · Cited by 30
Cited by
Gut Microbiota and Complications of Type-2 Diabetes
Iatcu, C. O., Steen, A., & Covasa, M. (2021) · Nutrients · doi:10.3390/nu14010166 · Cited by 418
Self-citationGLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Abdalqadir, N., & Adeli, K. (2022) · Microorganisms · doi:10.3390/microorganisms10102061 · Cited by 119
Kiosia, A., Dagbasi, A., Berkley, J. A., Wilding, J. P. H., Prendergast, A. J., Li, J. V., Swann, J., Mathers, J. C., Kerac, M., Morrison, D., et al. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12670 · Cited by 43
Mishima, M. D. V., Da Silva, B. P., Gomes, M. J. C., Toledo, R. C. L., Mantovani, H. C., José, V. P. B. D. S., Costa, N. M. B., Tako, E., & Martino, H. S. D. (2022) · Nutrients · doi:10.3390/nu14224924 · Cited by 23
Metadata
- Authors
- Covasa, M., Stephens, R. W., Toderean, R., & Cobuz, C.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2019-02-19
- Volume
- 10
- Pages
- 82-82
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2912898761
- Cited by
- 112
- References
- 82
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.